2-chloroadenosine has been researched along with clonazepam in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bauer, C; Caldwell, L; Kinnier, WJ; Lancaster, J; McMillan, B; Price, CH; Sweetnam, PM | 1 |
Advenier, C; Candenas, ML; Devillier, P; Naline, E | 1 |
Borowicz, KK; Czuczwar, SJ; Ćuszczki, J | 1 |
1 review(s) available for 2-chloroadenosine and clonazepam
Article | Year |
---|---|
The role of receptor binding in drug discovery.
Topics: Animals; Drug Design; Humans; Receptors, Drug | 1993 |
2 other study(ies) available for 2-chloroadenosine and clonazepam
Article | Year |
---|---|
Contractile effect of alpha,beta-methylene ATP on the guinea-pig isolated trachea.
Topics: 2-Chloroadenosine; Adenosine Triphosphate; Animals; Benzodiazepinones; Clonazepam; Diazepam; Drug Synergism; GABA-A Receptor Antagonists; Guinea Pigs; Male; Muscle Contraction; Muscle, Smooth; Phenylisopropyladenosine; Trachea | 1992 |
2-Chloroadenosine, a preferential agonist of adenosine A1 receptors, enhances the anticonvulsant activity of carbamazepine and clonazepam in mice.
Topics: 2-Chloroadenosine; Animals; Anticonvulsants; Carbamazepine; Clonazepam; Drug Synergism; Drug Therapy, Combination; Electroshock; Male; Mice; Purinergic P1 Receptor Agonists; Receptors, Purinergic P1; Seizures | 2002 |